These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells? Ren J; Ding T; Zhang W; Song J; Ma W Virol J; 2007 Sep; 4():83. PubMed ID: 17803826 [TBL] [Abstract][Full Text] [Related]
29. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. Alvarez CP; Lasala F; Carrillo J; Muñiz O; Corbí AL; Delgado R J Virol; 2002 Jul; 76(13):6841-4. PubMed ID: 12050398 [TBL] [Abstract][Full Text] [Related]
30. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity. Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855 [TBL] [Abstract][Full Text] [Related]
31. TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope. Yuan S; Cao L; Ling H; Dang M; Sun Y; Zhang X; Chen Y; Zhang L; Su D; Wang X; Rao Z Protein Cell; 2015 Nov; 6(11):814-24. PubMed ID: 26487564 [TBL] [Abstract][Full Text] [Related]
32. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. Yonezawa A; Cavrois M; Greene WC J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320 [TBL] [Abstract][Full Text] [Related]
34. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008 [TBL] [Abstract][Full Text] [Related]
35. Peptide inhibitors of dengue virus and West Nile virus infectivity. Hrobowski YM; Garry RF; Michael SF Virol J; 2005 Jun; 2():49. PubMed ID: 15927084 [TBL] [Abstract][Full Text] [Related]
36. Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission. Tabata T; Petitt M; Puerta-Guardo H; Michlmayr D; Wang C; Fang-Hoover J; Harris E; Pereira L Cell Host Microbe; 2016 Aug; 20(2):155-66. PubMed ID: 27443522 [TBL] [Abstract][Full Text] [Related]
37. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry. Wang J; Manicassamy B; Caffrey M; Rong L Virol Sin; 2011 Jun; 26(3):156-70. PubMed ID: 21667336 [TBL] [Abstract][Full Text] [Related]
39. RNA interference screen for human genes associated with West Nile virus infection. Krishnan MN; Ng A; Sukumaran B; Gilfoy FD; Uchil PD; Sultana H; Brass AL; Adametz R; Tsui M; Qian F; Montgomery RR; Lev S; Mason PW; Koski RA; Elledge SJ; Xavier RJ; Agaisse H; Fikrig E Nature; 2008 Sep; 455(7210):242-5. PubMed ID: 18690214 [TBL] [Abstract][Full Text] [Related]
40. Progress in the identification of dengue virus entry/fusion inhibitors. De La Guardia C; Lleonart R Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]